香川大学医学部薬理学　研究業績

2013 学会発表等（国際）~Publications(International)~

1	Azelnidipine enhances protective effects of olmesartan against bbb and renal injuries in type 2 diabetic mice, independent of blood pressure changes. Rafiq K, Nishiyama A.. World Congress of Nephrology. 2013.5. Hong Kong
2	Renal iron accumulation in type 1 diabetic mice is independent of cell senescence. Morita T, Nakano D, Kitada K, Nishiyama A.. World Congress of Nephrology. 2013.5. Hong Kong
3	Effects of olmesartan on albuminuria and urinary angiotensinogen excretion in patients with metabolic syndrome. Hitomi H,Kobori H, Nishiyama A.. World Congress of Nephrology. 2013.5. Hong Kong
4	Endothelial Cell-Derived ET-1 Contributes to the Severity of Septic Kidney Injury Nakano D, Emoto N, Nakayama K, Yanagisawa M, Nishiyama A. International Conference on Endothelin. 2013.9. Tokyo
5	Urinary Angiotensinogen Could be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes Mizushige T, Kobori H, Nishijima Y, Yano Y, Sakata K, Hayakawa M, Nishiyama A. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
6	Circadian Rhythm of Plasma and Urinary Angiotensinogen in Patients with Chronic Kidney Disease Nishijima Y, Kobori H, Mizushige T, Hara T, Nishiyama A, Kohno M. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
7	P21 is Essential for the Beneficical Effects of Renal Ischemic Preconditioning in Ischemic Acute Kidney Injury Nishioka S, Nakano D, Kitada K, Ohsaki H, Sofue T, Kohno M, Nishiyama A. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
8	An Iron Chelator, Deferasirox, Prevents Renal Iron Accumulation and Macrophage Infiltration But Not Cell Senescence inType 1 Diabetic Mice Nakano D, Morita T, Kitada K, Nishiyama A. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
9	AngiotensinⅡ Promotes Proliferation and Fibrosis in Parietal Epithelial Cells Contributing to the Development of Crescentic Glomerulonephritis Shibayama Y, Urushihara M, Nishiyama A, Kobori H. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
10	Combined Treatment With Irbesartan and Vitamin D Retards Renal Injury in Salt-loaded Uni-nephrectomized Stroke-prone Spontaneously Hypertensive Rats Takenaka T, Inoue T, Ohno Y, Miyazaki T, Nishiyama A, Ishii N, Suzuki H. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
11	Angiotensin Receptor Activation Contributes to Glucose Intolerance and Increased Insulin Resistance Independent of Elevated Systolic Blood Pressure Adiposity and Dyslipidemia in a Model of Metabolic Syndrome Lee AY, Rodrigez RR, Martinez B, Nakano D, Nishiyama A, Ortiz R. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
12	Angiotensin Receptor Blockade Ameliorates the Hypertension Associated with Acute Glucagon-like Peptide-1 Receptor Activation Rodriguez R, Lee A, Moreno M, Vazquez G, Ruilova SD, Nishiyama A, Ortiz RM. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
13	Intrarenal vs. systemic Nishiyama A.. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
14	Angiotensin Regulation Nishiyama A. High Blood Pressure Research Conference. 2013.9. New Orleans,LA
15	Suppression of insulin resistance by renal sympathetic denervation in obese rats. Rafiq K, Fujisawa Y, Asadur R, Sufin A, Nakano D, Nishiyama A. Annual Meetings of the American Society of Nephrology. 2013.11. Atlanta,GA
16	Incretin Hormones in CVD; Overview Nishiyama A. American Heart Association Scientific Session.. 2013.11. Dallas,TX
17	Proposal of One-Shot-type Spectroscopic-Tomography for Non-invasive Medical-measurement. Shun Sato, Masaru Fujiwara, Pradeep K. W. Abeygunawardhana, Satoru Suzuki, Akira Nishiyama, Ichiro Ishimaru. CLINICAL AND BIOMEDICAL SPECTROSCOPY AND IMAGING III 8798. 2013.6.